MARKET

VCEL

VCEL

Vericel
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.53
+0.10
+0.54%
After Hours: 18.53 0 0.00% 16:00 11/19 EST
OPEN
18.48
PREV CLOSE
18.43
HIGH
18.96
LOW
18.44
VOLUME
642.42K
TURNOVER
--
52 WEEK HIGH
21.01
52 WEEK LOW
13.40
MARKET CAP
828.19M
P/E (TTM)
-57.8340
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VCEL and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VCEL News

  • Edited Transcript of VCEL earnings conference call or presentation 5-Nov-19 1:30pm GMT
  • Thomson Reuters StreetEvents.11/09 11:03
  • Stock Market News for Nov 6, 2019
  • Zacks.11/06 15:18
  • Vericel Announces Appointment of Sean C. Flynn as Vice President and General Counsel
  • GlobeNewswire.11/06 14:00
  • Vericel Corporation (VCEL) CEO Nick Colangelo on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/05 19:26

More

Industry

Pharmaceuticals
+0.40%
Pharmaceuticals & Medical Research
+0.78%

Hot Stocks

Name
Price
%Change

About VCEL

Vericel Corporation is an integrated, commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of cellular therapies for use in the treatment of specific diseases.. Its autologous cell therapy products include Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.
More

Webull offers Vericel Corp (VCEL) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.